Myelodysplasia is in the niche: novel concepts and emerging therapies

por Bulycheva, E, Rauner, M, Medyouf, H, Theurl, I, Bornhäuser, M, Hofbauer, L C, Platzbecker, U
Publicado 2015

CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC

por Tirado-Gonzalez, I, Czlonka, E, Nevmerzhitskaya, A, Soetopo, D, Bergonzani, E, Mahmoud, A, Contreras, A, Jeremias, I, Platzbecker, U, Bourquin, J P, Kloz, U, Van der Hoeven, F, Medyouf, H
Publicado 2017

Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial

por Kubasch, A. S., Peterlin, P., Cluzeau, T., Götze, K. S., Sockel, K., Teipel, R., Jentzsch, M., Attalah, H., Sebert, M., Chermat, F., Gloaguen, S., Puttrich, M., Cross, M., Schneider, M., Kayser, S., Schipp, D., Giagounidis, A., Tirado-Gonzalez, I., Descot, A., van de Loosdrecht, A., Weigert, A., Metzeler, K. H., Fenaux, P., Medyouf, H., Platzbecker, U., Ades, L.
Publicado 2023